Brief: Zynerba Pharmaceuticals Presents Data On Zygel At The 55Th Gatlinburg Conference
12/04/2023 13:55
April 12 (Reuters) - Zynerba Pharmaceuticals Inc
ZYNE.O :
* ZYNERBA PHARMACEUTICALS PRESENTS DATA ON ZYGEL™ AT THE
55TH
GATLINBURG CONFERENCE
* ZYNERBA PHARMACEUTICALS INC - ZYGEL CONTINUED TO BE
WELL-TOLERATED WITH LONG-TERM ADMINISTRATION
* ZYNERBA PHARMACEUTICALS INC - ZYGEL MAINTAINED CLINICALLY
MEANINGFUL IMPROVEMENTS IN CHILDREN AND ADOLESCENTS WITH FRAGILE
X SYNDROME
Source text for Eikon: ID:nGNX1K4nfN
Further company coverage: ZYNE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary